Patients with metastatic prostate cancer will receive either talazoparib or placebo in combination with enzalutamide to determine if the addition of talazoparib to enzalutamide will provide additional benefit when compared to enzalutamide alone.

Start Over

2777 Mile High Stadium Cir Denver, CO USA

Recruitment Status: Open

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.

Powered by